Raffles Medical Group Ltd (SGX: BSL)
Health Care · Health Care Providers & Services · SG
S$0.82
-0.61% today · -18.0% 1Y
Raffles Medical Group Ltd (SGX: BSL) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.18B and employs 2,900 people.
Over the last twelve months the share price has lost 18.0%, trading between 0.81 and 1.08.
Tweenvest scores Raffles Medical Group Ltd across four factors: quality 79/100, value 68/100, growth 39/100, dividend 74/100. Its strongest factor is quality.
BSL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.18B
- Revenue (TTM)
- $572.07M
- P/E
- 22.46
- EPS
- 0.04
- Dividend yield
- 3.66%
- Beta (5Y)
- 0.23
- 52-week high
- S$1.08
- 52-week low
- S$0.81
- Avg volume (3M)
- —
- Shares outstanding
- 1.84B
- Employees
- 2,900
- Next earnings
- —
About Raffles Medical Group Ltd
Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
- ISIN
- SG1CH4000003
- Founded
- 1976
- Listed since
- Jan 3, 2000
- Exchange
- Singapore Exchange
- Currency
- SGD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Reform Health Management and Services Group Co., Ltd.SZSE: 000503 | $1.23B | CN¥8.43 | +9.62% |
| Ramsay Générale de Santé SAENXTPA: GDS | $1.23B | €9.90 | -0.60% |
| Park Medi World LimitedNSEI: PARKHOSPS | $1.21B | Rs270.80 | -5.43% |
| Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd.SZSE: 301584 | $1.18B | CN¥18.81 | +1.51% |
| Nanjing Xinjiekou Department Store Co., Ltd.SHSE: 600682 | $1.18B | CN¥5.86 | +0.34% |
| Genertec Universal Medical Group Company LimitedSEHK: 2666 | $1.17B | HK$4.56 | +1.22% |
| INKON Life Technology Co., Ltd.SZSE: 300143 | $1.15B | CN¥7.95 | +1.27% |
| Metropolis Healthcare LimitedNSEI: METROPOLIS | $1.13B | Rs529.25 | -1.61% |
Figures last refreshed Oct 11, 2026.